These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 19297385)

  • 1. Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis.
    Antoniades C; Shirodaria C; Leeson P; Antonopoulos A; Warrick N; Van-Assche T; Cunnington C; Tousoulis D; Pillai R; Ratnatunga C; Stefanadis C; Channon KM
    Eur Heart J; 2009 May; 30(9):1142-50. PubMed ID: 19297385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between vascular wall and perivascular adipose tissue reveal novel roles for adiponectin in the regulation of endothelial nitric oxide synthase function in human vessels.
    Margaritis M; Antonopoulos AS; Digby J; Lee R; Reilly S; Coutinho P; Shirodaria C; Sayeed R; Petrou M; De Silva R; Jalilzadeh S; Demosthenous M; Bakogiannis C; Tousoulis D; Stefanadis C; Choudhury RP; Casadei B; Channon KM; Antoniades C
    Circulation; 2013 Jun; 127(22):2209-21. PubMed ID: 23625959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels: effects on vascular tetrahydrobiopterin availability and endothelial nitric oxide synthase coupling.
    Antoniades C; Shirodaria C; Warrick N; Cai S; de Bono J; Lee J; Leeson P; Neubauer S; Ratnatunga C; Pillai R; Refsum H; Channon KM
    Circulation; 2006 Sep; 114(11):1193-201. PubMed ID: 16940192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered plasma versus vascular biopterins in human atherosclerosis reveal relationships between endothelial nitric oxide synthase coupling, endothelial function, and inflammation.
    Antoniades C; Shirodaria C; Crabtree M; Rinze R; Alp N; Cunnington C; Diesch J; Tousoulis D; Stefanadis C; Leeson P; Ratnatunga C; Pillai R; Channon KM
    Circulation; 2007 Dec; 116(24):2851-9. PubMed ID: 18040031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AVE3085 protects coronary endothelium from the impairment of asymmetric dimethylarginine by activation and recoupling of eNOS.
    Xue HM; Yu CM; Underwood MJ; Huang JH; Yang Q
    Cardiovasc Drugs Ther; 2012 Oct; 26(5):383-92. PubMed ID: 22890813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GCH1 haplotype determines vascular and plasma biopterin availability in coronary artery disease effects on vascular superoxide production and endothelial function.
    Antoniades C; Shirodaria C; Van Assche T; Cunnington C; Tegeder I; Lötsch J; Guzik TJ; Leeson P; Diesch J; Tousoulis D; Stefanadis C; Costigan M; Woolf CJ; Alp NJ; Channon KM
    J Am Coll Cardiol; 2008 Jul; 52(2):158-65. PubMed ID: 18598896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial nitric oxide synthase enhancer for protection of endothelial function from asymmetric dimethylarginine-induced injury in human internal thoracic artery.
    Xuan C; Chang FJ; Liu XC; Bai XY; Liao XL; He GW; Ou JS
    J Thorac Cardiovasc Surg; 2012 Sep; 144(3):697-703. PubMed ID: 22336756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress.
    Suda O; Tsutsui M; Morishita T; Tasaki H; Ueno S; Nakata S; Tsujimoto T; Toyohira Y; Hayashida Y; Sasaguri Y; Ueta Y; Nakashima Y; Yanagihara N
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1682-8. PubMed ID: 15217805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymmetrical dimethylarginine (ADMA) and coronary endothelial function in patients with coronary artery disease and mild hypercholesterolemia.
    Maas R; Quitzau K; Schwedhelm E; Spieker L; Rafflenbeul W; Steenpass A; Lüscher TF; Böger RH
    Atherosclerosis; 2007 Mar; 191(1):211-9. PubMed ID: 16828780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-citrulline for protection of endothelial function from ADMA-induced injury in porcine coronary artery.
    Xuan C; Lun LM; Zhao JX; Wang HW; Wang J; Ning CP; Liu Z; Zhang BB; He GW
    Sci Rep; 2015 Jun; 5():10987. PubMed ID: 26046576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid, direct effects of statin treatment on arterial redox state and nitric oxide bioavailability in human atherosclerosis via tetrahydrobiopterin-mediated endothelial nitric oxide synthase coupling.
    Antoniades C; Bakogiannis C; Leeson P; Guzik TJ; Zhang MH; Tousoulis D; Antonopoulos AS; Demosthenous M; Marinou K; Hale A; Paschalis A; Psarros C; Triantafyllou C; Bendall J; Casadei B; Stefanadis C; Channon KM
    Circulation; 2011 Jul; 124(3):335-45. PubMed ID: 21730307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil antimicrobial peptide alpha-defensin causes endothelial dysfunction in porcine coronary arteries.
    Kougias P; Chai H; Lin PH; Yao Q; Lumsden AB; Chen C
    J Vasc Surg; 2006 Feb; 43(2):357-63. PubMed ID: 16476615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
    Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
    Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between plasma asymmetrical dimethylarginine activity and saphenous vein graft disease in patients with coronary bypass.
    Cagirci G; Cay S; Karakurt O; Buyukterzi Z; Yazihan N; Kilic H; Topaloglu S; Aras D; Akdemir R
    Coron Artery Dis; 2010 Jan; 21(1):20-5. PubMed ID: 19996737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brachial artery flow-mediated dilation and asymmetrical dimethylarginine in the cardiovascular risk in young Finns study.
    Juonala M; Viikari JS; Alfthan G; Marniemi J; Kähönen M; Taittonen L; Laitinen T; Raitakari OT
    Circulation; 2007 Sep; 116(12):1367-73. PubMed ID: 17724260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ginsenoside Rb1 blocks homocysteine-induced endothelial dysfunction in porcine coronary arteries.
    Zhou W; Chai H; Lin PH; Lumsden AB; Yao Q; Chen C
    J Vasc Surg; 2005 May; 41(5):861-8. PubMed ID: 15886672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymmetric dimethylarginine determines the improvement of endothelium-dependent vasodilation by simvastatin: Effect of combination with oral L-arginine.
    Böger GI; Rudolph TK; Maas R; Schwedhelm E; Dumbadze E; Bierend A; Benndorf RA; Böger RH
    J Am Coll Cardiol; 2007 Jun; 49(23):2274-82. PubMed ID: 17560293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NAD(P)H oxidase inhibition improves endothelial function in rat and human blood vessels.
    Hamilton CA; Brosnan MJ; Al-Benna S; Berg G; Dominiczak AF
    Hypertension; 2002 Nov; 40(5):755-62. PubMed ID: 12411473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MTHFR 677 C>T Polymorphism reveals functional importance for 5-methyltetrahydrofolate, not homocysteine, in regulation of vascular redox state and endothelial function in human atherosclerosis.
    Antoniades C; Shirodaria C; Leeson P; Baarholm OA; Van-Assche T; Cunnington C; Pillai R; Ratnatunga C; Tousoulis D; Stefanadis C; Refsum H; Channon KM
    Circulation; 2009 May; 119(18):2507-15. PubMed ID: 19398669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymmetric Dimethylarginine Limits the Efficacy of Simvastatin Activating Endothelial Nitric Oxide Synthase.
    Hsu CP; Zhao JF; Lin SJ; Shyue SK; Guo BC; Lu TM; Lee TS
    J Am Heart Assoc; 2016 Apr; 5(4):e003327. PubMed ID: 27091343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.